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Summary
The data presented in this paper describe trends in treated problem drug use among
cases living in the Health Service Executive Eastern Region. The Eastern Region comprises
three Health Service Executive (HSE) areas, namely the HSE East Coast Area, the HSE
South Western Area and the HSE Northern Area, and covers three counties: Dublin,
Kildare and Wicklow. For a small number of cases, the precise electoral division of
residence was not recorded. Therefore, these cases could not be allocated to their HSE
area of residence and they have been categorised by county of residence, as Dublin
unspecified or Wicklow unspecified.
The analysis presented in this paper is based on data reported to the National Drug
Treatment Reporting System.
The main findings and their implications are:
• Of the 27,674 cases treated for problem drug use and living in the HSE Eastern
Region between 1998 and 2002, 4,871 (18%) were treated for the first time. Overall,
the total number of cases increased by 23 per cent over the five-year period. There
was an increase in the number and proportion of previously treated cases, from
3,815 (75%) in 1998 to 5,324 (85%) in 2002. There was a steady decrease in the
number and proportion of new cases, from 1,140 (22%) in 1998 to 790 (13%) in
2002. The increase in the total numbers can be attributed to the fact that the
numbers continuing in and returning to treatment were increasing by a larger rate
than the number of new cases entering treatment in each year. In addition, this
suggests that the increased service provision was to a large extent able to cope with
demand for drug treatment services from persons living in the HSE Eastern Region.
• The prevalence of treated problem drug use among persons aged between 15 and
64 years living in the HSE Eastern Region expressed per 100,000 of the population
was calculated. In the HSE Northern (Dublin) Area, there was an increase of 6 per
cent, from 652 per 100,000 in 1998 to 694 per 100,000 in 2001, but a subsequent
decrease of 11 per cent (to 617 per 100,000) in 2002. The prevalence of treated
drug use in the HSE South Western Area (of Dublin and Wicklow and all of Kildare)
increased by 6 per cent, from 603 per 100,000 in 1998 to 639 per 100,000 in 2002.
The prevalence of treated drug use in the HSE East Coast Area (of Dublin and
Wicklow) increased by 86 per cent, from 145 per 100,000 in 1998 to 270 per
100,000 in 2002.
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• The incidence of treated problem drug use among persons aged between 15 and 64 years living in the HSE
East Coast Area increased by 73 per cent, from 30 per 100,000 in 1998 to 52 per 100,000 in 2002. The
incidence in the HSE South Western Area (of Dublin and Wicklow and all of Kildare) halved, from 129 per
100,000 in 1998 to 63 per 100,000 in 2002 and the incidence in the HSE Northern Area almost halved
also, from 136 per 100,000 in 1998 to 71 per 100,000 in 2002. 
• The incidence of treated problem drug use among persons aged between 15 and 64 years by HSE area of
residence was calculated for the period 1998 to 2002: the incidence was highest in the HSE South Western
Area (with 104 cases per 100,000 of the 15 to 64 year old population), followed closely by the HSE
Northern (Dublin) Area (with 103 cases per 100,000), while the HSE East Coast Area (of Dublin and
Wicklow) had the lowest incidence (with 41 cases per 100,000).
• The incidence of treated problem drug use among persons aged between 15 and 64 years by county of
residence was calculated for the period 1998 to 2002. As expected, the incidence was highest in Dublin
(with 114 cases per 100,000 of the 15 to 64 year old population), followed by Wicklow (with 45 cases per
100,000). Kildare had the lowest incidence (with just under29 cases per 100,000).
• The incidence of treated problem drug use among persons aged between 15 and 64 years living in each
drugs task force area in the HSE Eastern Region was calculated for two overlapping time periods: 1998 to
2000 and 2000 to 2002. The incidence of treated drug use increased in three of the 13 drugs task force
areas between the two overlapping time periods. The incidence in Bray more than doubled (from 41 per
100,000 to 100 per 100,000). In Dunlaoghaire–Rathdown the incidence increased by 55 per cent (from 31
per 100,000 to 48 per 100,000), and in Finglas–Cabra the incidence also increased (from 101 per 100,000
to 133 per 100,000). The incidence of treated drug use in nine of the 13 drugs task force areas decreased.
Ballyfermot experienced a 44 per cent decrease in incidence (from 370 per 100,000 to 206 per 100,000),
followed by the Canal Communities which experienced a 40 per cent decrease (from 383 per 100,000 to
228 per 100,000). In Blanchardstown the incidence of treated drug use decreased by 39 per cent (from 117
per 100,000 to 71 per 100,000), while in Ballymun it decreased by 38 per cent (from 551 per 100,000 to
339 per 100,000). The incidence in the South Inner City remained largely unchanged over the two time
periods. These findings demonstrate the importance of analysis by small areas in order to identify the shift
of problematic drug use to new areas. 
• Between 1998 and 2002, opiates were the most common main problem drug reported by both new and
previously treated cases in the HSE Eastern Region. The total number of cases living in the region who
reported opiates as their main problem drug increased by 27 per cent, from 4,652 in 1998 to 5,921 in
2002, and opiates dominated the main problem drug profile among treated cases living in this area. The
numbers reporting problem cannabis use decreased by 14 per cent, from 206 in 1998 to 177 in 2002. This
may be due to a combination of under-reporting of such cases by treatment providers and a lack of
treatment places available for problem cannabis users, rather than to a reduction in the number of problem
cannabis users in the region. The total number of cases reporting cocaine as their main problem drug
increased by 30 per cent, from 56 in 1998 to 73 in 2002. The pattern of main problem drugs reported by
cases previously treated was similar to that reported by all cases, while the pattern reported by new cases
was different. The number of new cases treated who reported problem opiate use decreased by 29 per
cent, from 912 in 1998 to 648 in 2002. The number and proportion of new cases who reported cocaine as
their main problem drug remained small over the reporting period. In the HSE Eastern Region, the
difference between the numbers reporting cannabis use in the population and the numbers seeking
treatment for problem cannabis use was greater than that in any of the seven areas outside the region,
which indicates that treatment services in this area may need to cater for a number of licit and illicit drugs
used rather than focusing mainly on opiate treatment (NACD and DAIRU 2004; Kelleher et al. 2004).
• The proportion of treated cases living in the HSE Eastern Region who reported problems with more than
one drug increased by 6 per cent, from 69 per cent in 1998 to 75 per cent in 2002. 
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• Of the treated cases living in the HSE Eastern Region who reported problems with more than one drug, the
rank order of additional problem drugs, from most common to least common, differed between 1998 and
2002. Benzodiazepines were the most common additional problem drug used in each year. In 1998, opiates
were the second most common additional problem drug. Opiates were replaced by cannabis as the second
most common additional problem drug between 1999 and 2002, while cocaine moved up from fourth
most common in 1998, 1999 and 2000 to third most common in 2001 and 2002. 
• The association between the main problem drug and additional problem drugs among new treated cases
living in the HSE Eastern Region was examined for the period 1998 to 2002. The pattern of additional
problem drugs was linked to the main problem drug. For example, where an opiate was the main problem
drug, the most common additional problem drugs were cannabis, followed by benzodiazepines and then
cocaine; where cannabis was the main problem drug, the most common additional problem drugs were
ecstasy, followed by alcohol and then amphetamines. Information about the combinations of drugs used is
important in terms of individual clients’ care plans.
Glossary of terms
• The median is the value at the mid-point in a sequence of numerical values ranged in ascending or
descending order. It is defined as the value above or below which half of the values lie. Unlike the mean
(average), the median is not influenced by extreme values (or outliers). For example, in the case of five drug
users aged 22, 23, 24, 24 and 46 years respectively, the median (middle value) is 24 years, whereas the
mean is 27.8 years. While both the median and the mean describe the central value of the data, the median
is more useful since the mean is influenced by the one older person in this example. 
• Incidence is a term used to describe the number of new cases of disease or events that develop among a
population during a specified time interval. For example, in 2001, ten opiate users living in a specific county
sought treatment for the first time. The incidence is the number of opiate cases divided by the population
living in the county (say 31,182 persons in this example) expressed per given number of the population,
i.e., per 100, per 1,000, per 10,000, etc.
The calculation in this case is as follows: (10/31,182) x 10,000, which gives an incidence rate of 3.2 per
10,000 of the specific county population in 2001.
• Prevalence is a term used to describe the proportion of people in a population who have a disease or
condition at a specific point or period in time. For example, in 2001, ten opiate users living in a specific
county sought treatment for the first time, 20 opiate users returned to treatment in the year and five opiate
users continued in treatment from the previous year; in total there are 35 people treated for problem opiate
use in 2001. The prevalence is the total number of cases (35) divided by the population living in the county
(31,182 persons) expressed per given number of the population, i.e., per 100, per 1,000, per 10,000, etc. 
The calculation in this case is as follows: (35/31,182) x 10,000, which gives a prevalence rate of 11.2 per
10,000 of the specific county population in 2001.
• Epidemic disease levels exist when there is an excess number of new cases among a specific population 
for that point and place in time. An epidemic can also be called an outbreak. An excess number of cases 
is defined as a number greater than two standard deviations above the normal expected for that point 
in time. 
• Endemic disease levels exist when the numbers of new cases among a specific population are within the
normal range for the time of year and place of residence. The normal range is defined as the range within
two standard deviations of the normal expected for that point in time. 
continued overleaf  
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Glossary of terms (continued)
• Health boards and the Health Service Executive 
• On 1 January 2005, the ten health boards managing the health services in Ireland were replaced by a
single entity, the Health Service Executive (HSE). The former health boards were responsible for health
care provision to populations in specific geographical areas. In the interest of continuity of care, the HSE
has maintained these ten areas for an interim period and called them HSE areas. The former Eastern
Regional Health Authority is known as the HSE Eastern Region for this interim period. 
• When the HSE has established itself and redeployed staff, health care will be provided through four HSE
regions and 32 local health offices. The local health offices will be based on the geographical boundaries
of the existing community care areas. In this paper we have presented the data by HSE area (that is, by
the former health board boundaries) and by the new HSE Eastern Region order to reflect possible
planning needs. 
• The table below presents the past health board structure, the present interim structure and the proposed
future regional structure. 
Regional Health Authority Health boards HSE areas HSE regions 
Not applicable North Eastern Health Board HSE North Eastern Area 
HSE Dublin/North East RegionEastern Regional Health Northern Area Health Board HSE Northern Area
Authority (ERHA*) 
Eastern Regional Health East Coast Area Health Board HSE East Coast Area
Authority (ERHA)  
Eastern Regional Health South Western Area Health Board HSE South Western Area HSE Dublin/Mid-Leinster Region
Authority (ERHA)  
Not applicable Midland Health Board HSE Midland Area 
Not applicable South Eastern Health Board HSE South Eastern Area 
HSE Southern Region
Not applicable Southern Health Board HSE Southern Area 
Not applicable Mid-Western Health Board HSE Mid-Western Area 
Not applicable North Western Health Board HSE North Western Area HSE Western Region
Not applicable Western Health Board HSE Western Area 
*The ERHA is known as the HSE Eastern Region for the interim period.
Introduction
The National Drug Treatment Reporting System (NDTRS) is an epidemiological database on treated problem
drug use in Ireland. It was established in 1990 in the Greater Dublin Area and was extended in 1995 to cover
other areas of the country. The reporting system was originally developed in line with the Pompidou Group’s
Definitive Protocol (Hartnoll 1994) and subsequently refined in accordance with the Treatment Demand
Indicator Protocol (EMCDDA and Pompidou Group 2000). The NDTRS is co-ordinated by staff at the Drug
Misuse Research Division (DMRD) of the Health Research Board (HRB) on behalf of the Department of Health
and Children. 
Drug treatment data are viewed as an indirect indicator of drug misuse as well as a direct indicator of demand
for treatment services. These data are used at national and European levels to provide information on the
characteristics of clients entering treatment, and on patterns of drug misuse, such as types of drugs used and
consumption behaviours. They are ‘valuable from a public health perspective to assess needs, … and to plan
and evaluate services’ (EMCDDA 1998: 23). Information from the NDTRS is made available to service providers
and policy makers and is used to inform local and national drug policy and planning. For example, in 1996
NDTRS data were used to identify a number of local areas with problematic heroin use (Ministerial Task Force
1996). These areas were later designated as Local Drugs Task Force Areas and are continuing to provide
strategic responses to drug misuse in their communities. 
The monitoring role of the NDTRS is recognised by the Government in its document Building on Experience:
National Drugs Strategy 2001–2008. Data collection for the NDTRS is one of the actions identified and agreed
by Government for implementation by the former health boards: ‘All treatment providers should co-operate in
returning information on problem drug use to the DMRD of the HRB’ (Department of Tourism, Sport and
Recreation 2001: 118). 
Methods
Compliance with the NDTRS requires that one form be completed for each person who receives treatment for
problem drug use at each treatment centre in a calendar year. Service providers at drug treatment centres
throughout Ireland collect data on each individual treated for drug misuse. At national level, staff at the DMRD
of the HRB compile anonymous, aggregated data. 
For the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to ameliorate the
psychological, medical or social state of individuals who seek help for their drug problems’. Clients who attend
needle-exchange services are not included in this reporting system. Up to 2004, clients who reported alcohol as
their main problem drug were not included in this reporting system. Treatment options include one or more of
the following: medication (detoxification, methadone reduction and substitution programmes), addiction
counselling, group therapy, psychotherapy and/or life skills training. Treatment is provided in both residential
and non-residential settings (Table 1). Data returns to the NDTRS for clients living in the HSE Eastern Region
and attending treatment services in Ireland during 2002 were provided by 108 treatment services: 96 non-
residential and 12 residential. 
The main elements of the reporting system are defined as follows: 
All cases treated – describes individuals who receive treatment for problem drug use at each treatment
centre in a calendar year, and includes 
(a) Previously treated cases – describes individuals who were treated previously for problem drug use at
any treatment centre and have returned to treatment in the reporting year, or those individuals
continuing in treatment from the preceding calendar year
(b) New cases treated – describes individuals who have never been treated for problem drug use 
(c) Status unknown – describes individuals whose status with respect to previous treatment for
problem drug use is not known.
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In the case of the data for ‘previously treated cases’ there is a possibility of duplication in the database; for
example, where a person receives treatment at more than one centre. For those receiving methadone
maintenance or detoxification, this possibility is considered to be small since the introduction of the Misuse of
Drugs Regulations in 1998, whereby precautions are taken to ensure that methadone treatment is available from
one source only. 
The data presented in this paper describe trends in treated problem drug use among cases living in the HSE
Eastern Region. There were 27,674 cases treated for problem drug use living in the HSE Eastern Region between
1998 and 2002. The Eastern Region comprises three HSE areas, namely the HSE East Coast Area, the HSE South
Western Area and the HSE Northern Area, and covers three counties: Dublin, Kildare and Wicklow. For a small
number of cases, the precise electoral division of residence was not recorded. Therefore, these cases could not
be allocated to their HSE area of residence and they have been categorised by county of residence, as Dublin
unspecified or Wicklow unspecified. 
Analysis
The analysis presented provides an overview of cases treated for problem drug use living in the HSE Eastern
Region, that is, Dublin, Kildare and Wicklow. Service provision, numbers treated, incidence and prevalence of
treated drug misuse, drug-using practices, risk behaviours and socio-demographic characteristics are described
in this paper. 
Service provision
The total number of cases living in the HSE Eastern Region who were treated for problem drug use at outpatient
services increased from 3,899 in 1998 to 5,361 in 2002, while the total number treated in residential services
decreased substantially, from 974 in 1998 to 366 in 2002 (Table 1). In the HSE Eastern Region, counsellors
employed by statutory services did not consistently return information on cases who received counselling only,
therefore, there is an under-representation of cases treated for use of drugs other than opiates. Between 1998
and 2002, there was a large increase in the number of general practitioners providing methadone treatment
services in the HSE Eastern Region but, despite this, the number of general practitioners participating in the
NDTRS was still very low. For example, in 2002 there were 244 general practitioners prescribing methadone
treatment in the HSE Eastern Region, but only 24 (10%) of these provided returns to the NDTRS. Cases who
attended general practice may have differed from those who attended statutory treatment centres and this may
affect the generalisability of the findings presented in this paper. During the reporting period, the prison service
did not participate in the NDTRS, although it did provide drug treatment services. The findings must be
interpreted in the light of these limitations. There were inconsistencies in the NDTRS data collection, data
coding and data entry processes for data pertaining to the HSE Eastern Region up to and including 2000. These
have been rectified in the data presented in this paper; therefore, the numbers presented in this paper for the
years 1998 to 2000 differ from those presented in previous publications. 
Numbers treated
Of the 27,674 cases treated for problem drug use and living in the HSE Eastern Region between 1998 and
2002, 4,871 (18%) were treated for the first time. Overall, the total number of cases increased by 23 per cent
over the five-year period. There was an increase in the number and proportion of previously treated cases, from
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Table 1   Number and type of services providing treatment for cases (in brackets) reporting problem drug
use living in the HSE Eastern Region and reported to the NDTRS, 1998 to 2002
Drug services 1998 1999 2000 2001 2002 
Outpatient 50 (3899) 56 (3734) 57 (4312) 63 (5003) 70 (5361)
Residential 9 (974) 11 (733) 10 (465) 9 (394) 12 (366)
Low-threshold* 3 (182) 4 (282) 2 (279) 2 (215) 2 (149)
General practitioner 1 (24) 37 (396) 26 (267) 27 (256) 24 (364)
Prison 2 (4) 2 (7) 0 (0) 0 (0) 0 (0)
*Low-threshold services are services that provide low-dose methadone or drop-in facilities only.
3,815 (75%) in 1998 to 5,324 (85%) in 2002. There was a steady decrease in the number and proportion 
of new cases, from 1,140 (22%) in 1998 to 790 (13%) in 2002. The increase in the total numbers can be
attributed to the fact that the numbers continuing in and returning to treatment were increasing by a larger 
rate than the number of new cases entering treatment in each year. In addition, this suggests that the increased
service provision was to a large extent able to cope with demand for drug treatment services from persons
living in the HSE Eastern Region. 
Between 1998 and 2002, 45 per cent of treated drug users lived in the HSE South Western Area (of Dublin and
Wicklow and all of Kildare); 38 per cent lived in the HSE Northern (Dublin) Area; and less than one-tenth (9%)
lived in the HSE East Coast Area (of Dublin and Wicklow) (Table 3). However, the total number and proportion
of treated cases living in the HSE East Coast Area increased considerably, from 326 (6%) in 1998 to 647 (10%)
in 2002. The increase in the number of cases was not as dramatic for cases living in the other two HSE areas.
The number of previously treated cases followed a similar pattern to that of all cases in the three HSE areas. The
number of new cases living in the HSE East Coast Area increased from 68 in 1998 to 133 in 2002. The number
of new cases living in the HSE South Western Area decreased by 44 per cent, from 489 in 1998 to 275 in 2002.
A similar pattern was apparent for cases living in the HSE Northern Area, with the number of new cases
declining by 43 per cent, from 447 in 1998 to 254 in 2002. 
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Table 2   Number (%) of treated cases living in the HSE Eastern Region, by treatment status, reported to
the NDTRS, 1998 to 2002
Treatment status 1998 1999 2000 2001 2002 
Number (%)
All cases 5083 5152 5323 5868 6248
Previously treated 3815 (75.1) 3989 (77.4) 4293 (80.7) 4885 (83.2) 5324 (85.2)
New cases 1140 (22.4) 1080 (21.0) 958 (18.0) 903 (15.4) 790 (12.6)
Status unknown 128 (2.5) 83 (1.6) 72 (1.4) 80 (1.4) 134 (2.1)
Table 3   Number (%) of treated cases living in the HSE Eastern Region, by HSE area of residence and by
treatment status, reported to the NDTRS, 1998 to 2002
HSE area of residence 1998 1999 2000 2001 2002
Number (%)
All cases 5083 5152 5323 5868 6248
East Coast Area 
(of Dublin and Wicklow) 326 (6.4) 425 (8.2) 469 (8.8) 591 (10.1) 647 (10.4)
South Western Area
(of Dublin and Wicklow 
and all of Kildare) 2255 (44.4) 2482 (48.2) 2467 (46.3) 2434 (41.5) 2688 (43.0)
Northern (Dublin) Area 2107 (41.5) 1967 (38.2) 2060 (38.7) 2347 (40.0) 2141 (34.3)
Dublin unspecified 379 (7.5) 265 (5.1) 308 (5.8) 465 (7.9) 731 (11.7)
Wicklow unspecified 16 (0.3) 13 (0.3) 19 (0.4) 31 (0.5) 41 (0.7)
Previously treated cases 3815 3989 4293 4885 5324
East Coast Area
(of Dublin and Wicklow) 224 (5.9) 335 (8.4) 390 (9.1) 445 (9.1) 499 (9.4)
South Western Area
(of Dublin and Wicklow
and all of Kildare) 1738 (45.6) 1929 (48.4) 1930 (45.0) 2017 (41.3) 2363 (44.4)
Northern (Dublin) Area 1613 (42.3) 1486 (37.3) 1739 (40.5) 2022 (41.4) 1850 (34.7)
Dublin unspecified 231 (6.1) 230 (5.8) 224 (5.2) 381 (7.8) 581 (10.9)
Wicklow unspecified 9 (0.2) 9 (0.2) 10 (0.2) 20 (0.4) 31 (0.6)
New cases 1140 1080 958 903 790
East Coast Area
(of Dublin and Wicklow) 68 (6.0) 76 (7.0) 68 (7.1) 138 (15.3) 133 (16.8)
South Western Area
(of Dublin and Wicklow
and all of Kildare) 489 (42.9) 515 (47.7) 502 (52.4) 379 (42.0) 275 (34.8)
Northern (Dublin) Area 447 (39.2) 454 (42.0) 299 (31.2) 300 (33.2) 254 (32.2)
Dublin unspecified 129 (11.3) 31 (2.9) 80 (8.4) 75 (8.3) 118 (14.9)
Wicklow unspecified 7 (0.6) 4 (0.4) 9 (0.9) 11 (1.2) 10 (1.3)
Status unknown 128 83 72 80 134
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Incidence and prevalence of treated drug use
The analysis is based on the 27,674 treated cases living in the HSE Eastern Region between 1998 and 2002. In
order to adjust for variation in population size in each HSE area and county, the actual incidence of treated drug
use in each area was calculated using the average number of new cases over the five-year period living in each
of the three HSE areas and three counties; this average was divided by the population aged 15 to 64 years living
in the respective HSE areas and counties, using the census figures for 1998 and 2002 (Census 2003).
The incidence of treated problem drug use among persons aged between 15 and 64 years by HSE area of
residence was calculated for the period 1998 to 2002: the incidence was highest in the HSE South Western Area
(with 104 cases per 100,000 of the 15 to 64 year old population), followed closely by the HSE Northern Area
(with 103 cases per 100,000), while the HSE East Coast Area had the lowest incidence (with 41 cases per
100,000) (Figure 1).
The incidence of treated problem drug use among persons aged between 15 and 64 years by county of
residence was calculated for the period 1998 to 2002. As expected, the incidence was highest in Dublin (with
114 cases per 100,000 of the 15 to 64 year old population), followed by Wicklow (with 45 cases per 100,000).
Kildare had the lowest incidence (with just under 29 cases per 100,000) (Figure 2).
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Figure 1   Incidence of treated problem drug
use among persons aged between 15 and 64
years living in each HSE area, per 100,000
population (Central Statistics Office 2003),
based on returns to the NDTRS, 1998 to 2002 
Figure 2   Incidence of treated problem drug
use among persons aged between 15 and 64
years living in each county, per 100,000
population (Central Statistics Office 2003),
based on returns to the NDTRS, 1998 to 2002 
Figure 3a presents the incidence of treated problem drug use among persons aged between 15 and 64 years
living in the HSE Eastern Region. In the HSE East Coast Area, the incidence increased by 73 per cent, from 30
per 100,000 in 1998 to 52 per 100,000 in 2002. The incidence in the HSE South Western Area halved, from
129 per 100,000 in 1998 to 63 per 100,000 in 2002 and the incidence in the HSE Northern Area almost halved
also, from 136 per 100,000 in 1998 to 71 per 100,000 in 2002. 
Figure 3a   Incidence of treated problem drug use among persons aged between 15 and 64 years living in
the HSE Eastern Region, per 100,000 population (Central Statistics Office 2003), based on returns to the
NDTRS, 1998 to 2002 
Figure 3b presents the prevalence of treated problem drug use between 1998 and 2002 among persons aged
between 15 and 64 years living in the HSE Eastern Region, expressed per 100,000 of the population. In the HSE
Northern Area, there was an increase of 6 per cent, from 652 per 100,000 in 1998 to 694 per 100,000 in 2001,
but a subsequent decrease of 11 per cent (to 617 per 100,000) in 2002. The prevalence of treated drug use
among persons living in the HSE South Western Area increased by 6 per cent, from 603 per 100,000 in 1998 to
639 per 100,000 in 2002. The prevalence of treated drug use among persons living in the HSE East Coast Area
increased by 86 per cent, from 145 per 100,000 in 1998 to 270 per 100,000 in 2002. 
Figure 3b   Prevalence of treated problem drug use among persons aged between 15 and 64 years living
in the HSE Eastern Region, per 100,000 population (Central Statistics Office 2003), based on returns to
the NDTRS, 1998-2002 
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Figure 4a presents the incidence of treated problem drug use among persons aged between 15 and 64 years
living in each local drugs task force area (see introduction, second paragraph), and in other areas of each
county not designated as local drugs task force areas in the HSE Eastern Region, for two overlapping time
periods: 1998 to 2000 and 2000 to 2002. The incidence of treated drug use increased in three of the 13 drugs
task force areas between the two overlapping time periods. The incidence in Bray more than doubled (from 41
per 100,000 to 100 per 100,000). In Dunlaoghaire–Rathdown the incidence increased by 55 per cent (from 31
per 100,000 to 48 per 100,000), and in Finglas–Cabra the incidence also increased (from 101 per 100,000 to
133 per 100,000). The incidence of treated drug use in nine of the 13 drugs task force areas decreased.
Ballyfermot experienced a 44 per cent decrease in incidence (from 370 per 100,000 to 206 per 100,000),
followed by the Canal Communities, which experienced a 40 per cent decrease (from 383 per 100,000 to 228
per 100,000). In Blanchardstown the incidence of treated drug use decreased by 39 per cent (from 117 per
100,000 to 71 per 100,000), while in Ballymun it decreased by 38 per cent (from 551 per 100,000 to 339 per
100,000). The incidence in the South Inner City remained largely unchanged over the two time periods. 
Figure 4a   Incidence of treated problem drug use among persons aged between 15 and 64 years living in
each local drugs task force area, and in other areas of each county not designated as local drugs task
force areas in the HSE Eastern Region, for two time periods, 1998 to 2000 and 2000 to 2002, per 100,000
population (Central Statistics Office 2003), based on returns to the NDTRS 
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Figure 4b presents the incidence of treated opiate use among persons aged between 15 and 64 years living in
each local drugs task force area, and in other areas of each county not designated as local drugs task force areas
in the HSE Eastern Region, for two overlapping time periods: 1998 to 2000 and 2000 to 2002. The incidence of
treated opiate use increased in four of the 13 drugs task force areas over the two overlapping time periods. The
incidence of treated opiate use in Bray more than trebled in the later time period when compared to the earlier
time period (from 27 per 100,000 to 93 per 100,000). Over the two time periods, the incidence in
Dunlaoghaire–Rathdown increased considerably (by 50%, from 26 per 100,000 to 39 per 100,000) and also in
Finglas–Cabra (by 36%, from 86 per 100,000 to 117 per 100,000), while the South Inner City experienced a
small increase. The incidence of treated opiate use decreased in nine of the 13 drugs task force areas. The larger
decreases in incidence over the two time periods were in Ballyfermot (by 43%, from 340 per 100,000 to 194
per 100,000) and in the Canal Communities (by 43%, from 355 per 100,000 to 201 per 100,000), followed by
Blanchardstown (by 42%, from 104 per 100,000 to 60 per 100,000) and Ballymun (by 42%, from 525 per
100,000 to 302 per 100,000). 
Figure 4b   Incidence of treated opiate use among persons aged between 15 and 64 years living in each
local drugs task force area, and in other areas of each county not designated as local drugs task force
areas in the HSE Eastern Region, for two time periods, 1998 to 2000 and 2000 to 2002, per 100,000
population (Central Statistics Office 2003), based on returns to the NDTRS 
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Figure 4c presents the incidence of treated non-opiate use among persons aged between 15 and 64 years living
in each local drugs task force area, and in other areas of each county not designated as local drugs task force
areas in the HSE Eastern Region, for two overlapping time periods: 1998 to 2000 and 2000 to 2002. The
incidence of treated non-opiate use increased in three of the 13 drugs task force areas over the two time
periods. Although the incidence in Dunlaoghaire–Rathdown was relatively low, it represented the largest
percentage increase (from 5 per 100,000 to 9 per 100,000). The incidence of treated non-opiate use in
Ballymun increased by 42 per cent (from 26 per 100,000 to 37 per 100,000), while the incidence increased
marginally in Finglas–Cabra (from 15.5 per 100,000 to 15.7 per 100,000). The incidence of treated non-opiate
use decreased in ten of the 13 drugs task force areas. The largest decreases in incidence were in Ballyfermot (by
60%, from 30 per 100,000 to 12 per 100,000) and Bray (by 60%, from 15 per 100,000 to 6 per 100,000),
followed by Tallaght (by 59%, from 17 per 100,000 to 7 per 100,000) and Clondalkin (by 56%, from 16 per
100,000 to 7 per 100,000). 
Figure 4c   Incidence of treated non-opiate use among persons aged between 15 and 64 years living in
each local drugs task force area, and in other areas of each county not designated as local drugs task
force areas in the HSE Eastern Region for two time periods, 1998 to 2000 and 2000 to 2002, per 100,000
population (Central Statistics Office 2003), based on returns to the NDTRS 
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Main and additional problem drugs
Between 1998 and 2002, the most common main problem drug reported by both new and previously treated
cases in the HSE Eastern Region was opiates. The total number of cases reporting opiates as their main problem
drug increased by 27 per cent, from 4,652 in 1998 to 5,921 in 2002, and opiates dominate the main problem
drug profile among treated cases living in this area. The numbers reporting problem cannabis use decreased by
14 per cent, from 206 in 1998 to 177 in 2002. This may be due to a combination of under-reporting of such
cases by treatment providers and a lack of treatment places available for problem cannabis users rather than to
a reduction in the number of problem cannabis users in the region. The total number of cases reporting cocaine
as their main problem drug increased by 30 per cent, from 56 in 1998 to 73 in 2002. The pattern of main
problem drugs reported by cases previously treated was similar to that reported by all cases, while the pattern
reported by new cases was different. The number of new cases treated who reported problem opiate use
decreased by 29 per cent, from 912 in 1998 to 648 in 2002. The number and proportion of new cases who
reported cocaine as their main problem drug remained small over the reporting period. In the HSE Eastern
Region, the difference between the numbers reporting cannabis use in the population and the numbers seeking
treatment for problem cannabis use was greater than that in any of the seven areas outside the region, which
indicates that treatment services in this area may need to cater for a number of licit and illicit drugs used rather
than focusing mainly on opiate treatment (NACD and DAIRU 2004; Kelleher et al. 2004).
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Table 4   Main problem drug reported by treated cases living in the HSE Eastern Region, by treatment
status, and reported to the NDTRS, 1998 to 2002
Main problem drug 1998 1999 2000 2001 2002
Number (%)
All cases 5070 5152 5323 5868 6248
Opiates 4652 (91.8) 4840 (93.9) 5031 (94.5) 5631 (96.0) 5921 (94.8)
Cannabis 206 (4.1) 168 (3.3) 137 (2.6) 95 (1.6) 177 (2.8)
Cocaine 56 (1.1) 32 (0.6) 47 (0.9) 43 (0.7) 73 (1.2)
Benzodiazepines 57 (1.1) 27 (0.5) 56 (1.1) 57 (1.0) 42 (0.7)
Ecstasy 46 (0.9) 50 (1.0) 32 (0.6) 30 (0.5) 18 (0.3)
Amphetamines 24 (0.5) 18 (0.3) 2 (0.0) 4 (0.1) 1 (0.0)
Volatile inhalants 18 (0.4) 8 (0.2) 11 (0.2) 3 (0.1) 3 (0.0)
Other substances 11 (0.2) 9 (0.2) 7 (0.1) 5 (0.1) 13 (0.2)
Previously treated cases 3806 3989 4293 4885 5324
Opiates 3636 (95.5) 3868 (97.0) 4166 (97.0) 4772 (97.7) 5161 (96.9)
Cannabis 67 (1.8) 58 (1.5) 41 (1.0) 31 (0.6) 65 (1.2)
Benzodiazepines 42 (1.1) 21 (0.5) 48 (1.1) 45 (0.9) 33 (0.6)
Cocaine 32 (0.8) 18 (0.5) 25 (0.6) 23 (0.5) 46 (0.9)
Ecstasy 9 (0.2) 11 (0.3) 9 (0.2) 9 (0.2) 9 (0.2)
Amphetamines 9 (0.2) 5 (0.1) 0 (0.0) 2 (0.0) 0 (0.0)
Volatile inhalants 5 (0.1) 3 (0.1) 1 (0.0) 1 (0.0) 1 (0.0)
Other substances 6 (0.2) 5 (0.1) 3 (0.1) 2 (0.0) 9 (0.2)
New cases 1137 1080 958 903 790
Opiates 912 (80.2) 901 (83.4) 800 (83.5) 793 (87.8) 648 (82.0)
Cannabis 126 (11.1) 105 (9.7) 93 (9.7) 56 (6.2) 98 (12.4)
Ecstasy 33 (2.9) 36 (3.3) 23 (2.4) 21 (2.3) 7 (0.9)
Cocaine 23 (2.0) 14 (1.3) 20 (2.1) 17 (1.9) 22 (2.8)
Amphetamines 15 (1.3) 13 (1.2) 2 (0.2) 2 (0.2) 1 (0.1)
Volatile inhalants 13 (1.1) 5 (0.5) 10 (1.0) 2 (0.2) 2 (0.3)
Benzodiazepines 10 (0.9) 2 (0.2) 6 (0.6) 9 (1.0) 9 (1.1)
Other substances 5 (0.4) 4 (0.4) 4 (0.4) 3 (0.3) 3 (0.4)
Status unknown 127 83 72 80 134
The main problem drug reported by new cases treated was examined by HSE area of residence between 1998
and 2002 (Table 5). For new cases living in each HSE area, an opiate was the most commonly reported main
problem drug, while cannabis was the second most commonly reported drug.
The proportion of treated cases living in the HSE Eastern Region who reported problems with more than one
drug increased by 6 per cent, from 69 per cent in 1998 to 75 per cent in 2002 (Table 6). The same pattern was
noted among both new and previously treated cases.
Between 1998 and 2002, excluding Dublin unspecified and Wicklow unspecified, the highest proportions of
new cases reporting problems with more than one drug lived in the HSE East Coast Area (Table 7).
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Table 5   Main problem drug reported by new cases, by HSE area of residence, and reported to the
NDTRS, 1998 to 2002
Main problem drug East Coast South Western Northern Dublin Wicklow
Area Area Area unspecified unspecified
Number (%)
New cases 483 2157 1754 433 41
Opiates 394 (81.6) 1838 (85.2) 1439 (82.0) 356 (82.2) 27 (65.9)
Cannabis 54 (11.2) 172 (8.0) 197 (11.2) 43 (9.9) 12 (29.3)
Ecstasy 13 (2.7) 68 (3.2) 28 (1.6) 11 (2.5) 0 (0.0)
Cocaine 8 (1.7) 40 (1.9) 38 (2.2) 10 (2.3) 0 (0.0)
Benzodiazepines 7 (1.4) 11 (0.5) 12 (0.7) 5 (1.2) 1 (2.4)
Amphetamines 1 (0.2) 15 (0.7) 13 (0.7) 3 (0.7) 1 (2.4)
Volatile inhalants 2 (0.4) 10 (0.5) 18 (1.0) 2 (0.5) 0 (0.0)
Other substances 4 (0.8) 3 (0.1) 9 (0.5) 3 (0.7) 0 (0.0)
Table 7   Use of more than one drug by new cases, by HSE area of residence, and reported to the NDTRS,
1998 to 2002
East Coast South Western Northern Dublin Wicklow
Area Area Area unspecified unspecified
Number (%)
New cases 483 2160 1754 433 41
New cases who used 
more than one drug 315 (65.2) 1289 (59.7) 1090 (62.1) 307 (70.9) 29 (70.7)
Table 6   Use of more than one drug by cases living in the HSE Eastern Region, by treatment status, and
reported to the NDTRS, 1998 to 2002
1998 1999 2000 2001 2002
Number (%)
All cases 5083 5152 5323 5868 6248
All cases who used more 
than one drug 3481 (68.5) 3501 (68.0) 3589 (67.4) 4311 (73.5) 4671 (74.8)
Previously treated cases 3815 3989 4293 4885 5324
Previously treated cases who 
used more than one drug 2706 (70.9) 2831 (71.0) 2965 (69.1) 3673 (75.2) 4040 (75.9)
New cases 1140 1080 958 903 790
New cases who used more 
than one drug 704 (61.8) 622 (57.6) 577 (60.2) 580 (64.2) 547 (69.2)
Status unknown 128 83 72 80 134 
Status unknown cases who 
used more than one drug 71 (55.5) 48 (57.8) 47 (65.3) 58 (72.5) 84 (62.7) 
Of all treated cases living in the HSE Eastern Region between 1998 and 2002, 30 per cent reported problem use
of one drug, 33 per cent reported problem use of two drugs, 25 per cent reported problems with three drugs
and 13 per cent reported problems with four or more drugs (Table 8). A similar pattern was noted among
previously treated cases, while new cases differed slightly. For example in 2002, a larger proportion of new cases
than previously treated cases reported problems with one drug (31% versus 24%), while a smaller proportion
reported problems with four or more drugs (15% versus 19%).
Between 1998 and 2002, a higher proportion of new cases living in the HSE East Coast Area and HSE Northern
Area reported problem use of three or more drugs than the proportions in the HSE South Western Area (Table
9). Use of more than one drug is a common practice, increases the complexity of such cases, and is associated
with poorer outcomes.
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Table 8   Number of problem drugs used by cases living in the HSE Eastern Region, by treatment status,
and reported to the NDTRS, 1998 to 2002
Number of problem 1998 1999 2000 2001 2002
drugs used Number (%)
All cases 5083 5152 5323 5868 6248
Used 1 drug 1601 (31.5) 1651 (32.0) 1734 (32.6) 1557 (26.5) 1577 (25.2) 
Used 2 drugs 1762 (34.7) 1566 (30.4) 1791 (33.6) 2011 (34.3) 1988 (31.8) 
Used 3 drugs 1616 (31.8) 1217 (23.6) 1112 (20.9) 1396 (23.8) 1535 (24.6) 
Used 4 drugs or more 104 (2.0) 718 (13.9) 686 (12.9) 904 (15.4) 1148 (18.4) 
Previously treated cases 3815 3989 4293 4885 5324 
Used 1 drug 1108 (29.0) 1158 (29.0) 1328 (30.9) 1212 (24.8) 1284 (24.1) 
Used 2 drugs 1318 (34.5) 1270 (31.8) 1447 (33.7) 1676 (34.3) 1671 (31.4) 
Used 3 drugs 1299 (34.0) 976 (24.5) 941 (21.9) 1197 (24.5) 1363 (25.6) 
Used 4 drugs or more 90 (2.4) 585 (14.7) 577 (13.4) 800 (16.4) 1006 (18.9) 
New cases 1140 1080 958 903 790 
Used 1 drug 436 (38.2) 458 (42.4) 381 (39.8) 323 (35.8) 243 (30.8) 
Used 2 drugs 402 (35.3) 268 (24.8) 317 (33.1) 304 (33.7) 262 (33.2) 
Used 3 drugs 290 (25.4) 227 (21.0) 159 (16.6) 182 (20.2) 163 (20.6) 
Used 4 drugs or more 12 (1.1) 127 (11.8) 101 (10.5) 94 (10.4) 122 (15.4) 
Status unknown 128 83 72 80 134
Table 9   Number of problem drugs used by new cases, by HSE area of residence, and reported to the
NDTRS, 1998 to 2002 
Number of problem East Coast South Western Northern Dublin Wicklow
drugs used Area Area Area unspecified unspecified
Number (%)
New cases 483 2160 1754 433 41 
Used 1 drug 168 (34.8) 871 (40.3) 664 (37.9) 126 (29.1) 12 (29.3) 
Used 2 drugs 159 (32.9) 691 (32.0) 535 (30.5) 152 (35.1) 16 (39.0) 
Used 3 drugs 107 (22.2) 424 (19.6) 378 (21.6) 102 (23.6) 10 (24.4) 
Used 4 drugs or more 49 (10.1) 174 (8.1) 177 (10.1) 53 (12.2) 3 (7.3) 
Of the treated cases living in the HSE Eastern Region who reported problems with more than one drug, the rank
order of additional problem drugs from most common to least common differed between 1998 and 2002
(Table 10). Benzodiazepines were the most common additional problem drug reported for each year. In 1998,
opiates were the second most common additional problem drug. Opiates were replaced by cannabis as the
second most common additional problem drug between 1999 and 2002, while cocaine moved up from fourth
most common in 1998, 1999 and 2000 to third most common in 2001 and 2002. 
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Table 10   Additional problem drugs used by cases living in the HSE Eastern Region, by treatment status,
and reported to the NDTRS, 1998 to 2002
Additional problem 1998 1999 2000 2001 2002
drugs used* Number (%)
All cases who used 
additional drug(s) 3482 3501 3589 4311 4670
Benzodiazepines 1481 (42.5) 1659 (47.4) 1753 (48.8) 2281 (52.9) 2460 (52.7) 
Cannabis 1181 (33.9) 1423 (40.6) 1459 (40.7) 2071 (48.0) 2361 (50.6) 
Opiates 1299 (37.3) 1143 (32.6) 1067 (29.7) 976 (22.6) 1076 (23.0) 
Cocaine 405 (11.6) 673 (19.2) 731 (20.4) 1003 (23.3) 1408 (30.1) 
Ecstasy 347 (10.0) 520 (14.9) 487 (13.6) 590 (13.7) 570 (12.2) 
Alcohol 179 (5.1) 199 (5.7) 164 (4.6) 228 (5.3) 311 (6.7) 
Amphetamines 106 (3.0) 121 (3.5) 101 (2.8) 66 (1.5) 70 (1.5) 
Volatile inhalants 12 (0.3) 31 (0.9) 24 (0.7) 22 (0.5) 25 (0.5) 
Other substances 180 (5.2) 244 (7.0) 175 (4.9) 178 (4.1) 142 (3.0) 
Previously treated cases 
who used additional drug(s) 2707 2831 2965 3673 4039
Benzodiazepines 1264 (46.7) 1438 (50.8) 1569 (52.9) 2077 (56.5) 2248 (55.7) 
Cannabis 834 (30.8) 1087 (38.4) 1129 (38.1) 1733 (47.2) 2050 (50.8) 
Opiates 1112 (41.1) 999 (35.3) 920 (31.0) 824 (22.4) 907 (22.5) 
Cocaine 332 (12.3) 546 (19.3) 632 (21.3) 876 (23.8) 1246 (30.8) 
Ecstasy 224 (8.3) 374 (13.2) 380 (12.8) 480 (13.1) 474 (11.7) 
Alcohol 126 (4.7) 139 (4.9) 122 (4.1) 177 (4.8) 230 (5.7) 
Amphetamines 56 (2.1) 65 (2.3) 60 (2.0) 49 (1.3) 53 (1.3) 
Volatile inhalants 9 (0.3) 21 (0.7) 13 (0.4) 11 (0.3) 20 (0.5) 
Other substances 129 (4.8) 182 (6.4) 137 (4.6) 150 (4.1) 117 (2.9) 
New cases who used 
additional drug(s) 704 622 577 580 547
Cannabis 326 (46.3) 316 (50.8) 303 (52.5) 308 (53.1) 277 (50.6) 
Benzodiazepines 189 (26.8) 204 (32.8) 168 (29.1) 189 (32.6) 184 (33.6) 
Opiates 167 (23.7) 130 (20.9) 138 (23.9) 141 (24.3) 149 (27.2) 
Ecstasy 115 (16.3) 141 (22.7) 101 (17.5) 99 (17.1) 89 (16.3) 
Cocaine 67 (9.5) 121 (19.5) 90 (15.6) 112 (19.3) 137 (25.0) 
Amphetamines 49 (7.0) 52 (8.4) 39 (6.8) 16 (2.8) 14 (2.6) 
Alcohol 41 (5.8) 56 (9.0) 40 (6.9) 50 (8.6) 70 (12.8) 
Volatile inhalants 3 (0.4) 10 (1.6) 11 (1.9) 10 (1.7) 5 (0.9) 
Other substances 46 (6.5) 58 (9.3) 35 (6.1) 20 (3.4) 20 (3.7) 
Status unknown 71 48 47 58 84 
*By cases reporting use of one, two or three additional drugs.
The type and rank order of additional problem drugs reported by new cases were the same for cases living in
the three HSE areas (Table 11). 
The association between the main problem drug and additional problem drugs among new treated cases living
in the HSE Eastern Region was examined for the period 1998 to 2002 (Table 12). The pattern of additional
problem drugs was linked to the main problem drug. For example, where an opiate was the main problem
drug the most common additional problem drugs were cannabis, followed by benzodiazepines and then
cocaine; where cannabis was the main problem drug, the most common additional problem drugs were
ecstasy, followed by alcohol and then amphetamines. Information about the combinations of drugs used is
important in terms of individual clients’ care plans.
Risk behaviours
Between 1998 and 2000, 50 per cent of treated drug users living in the HSE Eastern Region commenced illicit
use of drugs before they were 15 years old, while in 2000 and 2001, half of treated drug users commenced
illicit use of drugs before they were 14 years old (Table 13). Of those living in the HSE Eastern Region who ever
injected illicit drugs, 50 per cent started injecting before they were 19 years old. With respect to the age at
which use of illicit drugs commenced and the age at which injection of illicit drugs commenced, both new and
previously treated cases reported similar age ranges.
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Table 11   Additional problem drugs used by new cases, by HSE area of residence, and reported to the
NDTRS, 1998 to 2002
Additional problem East Coast South Western Northern Dublin Wicklow
drugs used* Area Area Area unspecified unspecified
Number (%)
New cases who used 315 1289 1090 307 29
additional drug(s)
Cannabis 157 (49.8) 653 (50.7) 532 (48.8) 174 (56.7) 14 (48.3)
Benzodiazepines 106 (33.7) 395 (30.6) 364 (33.4) 67 (21.8) 2 (6.9)
Opiates 80 (25.4) 286 (22.2) 284 (26.1) 70 (22.8) 5 (17.2)
Ecstasy 57 (18.1) 217 (16.8) 197 (18.1) 68 (22.1) 6 (20.7)
Cocaine 51 (16.2) 235 (18.2) 198 (18.2) 41 (13.4) 2 (6.9)
Alcohol 26 (8.3) 91 (7.1) 81 (7.4) 50 (16.3) 9 (31.0)
Amphetamines 21 (6.7) 84 (6.5) 44 (4.0) 16 (5.2) 5 (17.2)
Volatile inhalants 1 (0.3) 13 (1.0) 22 (2.0) 2 (0.7) 1 (3.4)
Other substances 17 (5.4) 64 (5.0) 72 (6.6) 25 (8.1) 1 (3.4)
*By new cases reporting use of one, two or three additional drugs.
Table 12   Main problem drug and associated additional problem drugs used by new cases (number and
%) living in the HSE Eastern Region and reported to the NDTRS, 1998 to 2002
Main problem drug used*
Benzo- Volatile
Opiates Cannabis Ecstasy Cocaine Amphetamines diazepines inhalants
2246 208 85 65 20 19 9
Number (%)
Additional problem
drugs used†
Other opiates 596 (26.5) 30 (14.4) 10 (11.8) 13 (20.0) 1 (5.0) 7 (36.8) 0 (0.0)
Ecstasy 318 (14.2) 105 (50.5) 0 (0.0) 24 (36.9) 8 (40.0) 0 (0.0) 1 (11.1)
Cocaine 437 (19.5) 27 (13.0) 11 (12.9) 0 (0.0) 5 (25.0) 4 (21.1) 0 (0.0)
Amphetamines 52 (2.3) 50 (24.0) 32 (37.6) 9 (13.8) 0 (0.0) 2 (10.5) 0 (0.0)
Other benzodiazepines 872 (38.8) 13 (6.3) 4 (4.7) 3 (4.6) 0 (0.0) 3 (15.8) 1 (11.1)
Volatile inhalants 13 (0.6) 19 (9.1) 3 (3.5) 1 (1.5) 0 (0.0) 0 (0.0) 0 (0.0)
Cannabis 1187 (52.8) 0 (0.0) 68 (80.0) 39 (60.0) 13 (65.0) 7 (36.8) 8 (88.9)
Alcohol 93 (4.1) 62 (29.8) 12 (14.1) 16 (24.6) 0 (0.0) 4 (21.1) 3 (33.3)
*By new cases reporting use of more than one problem drug.
†By new cases reporting use of between one and three additional drugs. 
The number and proportion of previously treated injector cases living in the HSE Eastern Region increased (Table
13). The number of previously treated injector cases increased by 45 per cent, from 2,967 in 1998 to 4,297 in
2002, while the proportion of previously treated cases increased marginally in the same period. The number of
new injector cases living in the HSE Eastern Region decreased by 32 per cent, from 540 in 1998 to 369 in 2002;
this decrease is in line with the decrease in the number of new opiate cases living in the HSE Eastern Region.
Half of the injector cases living in the HSE Eastern Region had started injecting before they were 19 years old.
More worryingly, the total number of treated cases who reported ever sharing injecting equipment increased by
54 per cent, from 2,127 in 1998 to 3,285 in 2002. Injectors have a higher risk of acquiring blood-borne viral
infections and of experiencing overdose than do non-injectors. This suggests that the drug treatment services in
the HSE Eastern Region need to continue to promote the existing harm reduction services in order to prevent
blood-borne viral infections (in particular HIV, hepatitis B, and hepatitis C) and drug overdose (in particular
opiate-related overdose). Of note, the proportion of previously treated cases who reported injecting in the last
month decreased from 51 per cent in 1998 to 35 per cent in 2002, and sharing decreased from 13 per cent in
1998 to 6 per cent 2002. Since the majority of previously treated cases were continuing in care from the
previous year, this suggests that drug users who attended treatment were enabled to reduce their risk
behaviours.
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Table 13   Risk behaviours among cases living in the HSE Eastern Region, by treatment status, and
reported to the NDTRS, 1998 to 2002
Injecting and sharing status 1998 1999 2000 2001 2002
All cases 
injector status known 4855 5036 5227 5764 6096
Median age (range)*
started drug use, in years 15 (11-22) 15 (11-22) 15 (11-21) 14 (11-21) 14 (11-21)
Median age (range)*
started injecting, in years 19 (15-27) 19 (14-28) 19 (14-28) 19 (14-29) 19 (15-29) 
Number (%) ever injected 3578 (73.7) 3964 (78.7) 4248 (81.3) 4449 (77.2) 4729 (77.6) 
Of whom:†
‘ever shared’ 2127 (59.4) 2559 (64.6) 2884 (67.9) 3121 (70.2) 3285 (69.5) 
‘currently injecting’ 1890 (52.8) 1794 (45.3) 1846 (43.5) 1866 (41.9) 1759 (37.2) 
‘currently sharing’ 503 (14.1) 483 (12.2) 460 (10.8) 368 (8.3) 288 (6.1) 
Previously treated cases 
injector status known 3660 3912 4219 4805 5211
Median age (range)*
started drug use, in years 15 (11-22) 15 (11-22) 15 (11-21) 14 (11-21) 14 (11-20) 
Median age (range)*
started injecting, in years 19 (15-27) 18 (14-27) 19 (14-28) 19 (14-28) 19 (15-28) 
Number (%) ever injected 2967 (81.1) 3300 (84.4) 3665 (86.9) 3964 (82.5) 4297 (82.5) 
Of whom:†
‘ever shared’ 1842 (62.1) 2209 (66.9) 2592 (70.7) 2877 (72.6) 3091 (71.9) 
‘currently injecting’ 1509 (50.9) 1416 (42.9) 1523 (41.6) 1552 (39.2) 1488 (34.6) 
‘currently sharing’ 399 (13.4) 372 (11.3) 383 (10.5) 287 (7.2) 237 (5.5) 
New cases 
injector status known 1091 1050 941 885 772
Median age (range)*
started drug use, in years 15 (11-21) 15 (12-22) 15 (11-22) 15 (11-23) 15 (11-24)
Median age (range)*
started injecting, in years 19 (15-28) 19 (15-30) 19 (15-30) 19 (15-32) 19 (15-32) 
Number (%) ever injected 540 (49.5) 611 (58.2) 531 (56.4) 435 (49.2) 369 (47.8) 
Of whom:†
‘ever shared’ 246 (45.6) 324 (53.0) 270 (50.8) 228 (52.4) 172 (46.6) 
‘currently injecting’ 338 (62.6) 348 (57.0) 298 (56.1) 279 (64.1) 232 (62.9) 
‘currently sharing’ 92 (17.0) 108 (17.7) 73 (13.7) 76 (17.5) 47 (12.7) 
Status unknown 104 74 67 74 113 
* Age range presented is the 5th to 95th percentile (90% of all cases are within this age range).
† From the data presented in this table, it is not possible to ascertain the exact percentage of injectors with each risk factor of interest because not all declared
injectors were asked the subsequent injecting questions.
Between 1998 and 2002, the median age at which new cases commenced drug use and the median age at
which they commenced injecting was the same across the three HSE areas (Table 14). The highest proportion of
new cases who reported ever injecting illicit drugs lived in the HSE East Coast Area.
Socio-demographic characteristics
The median age of new and previously treated cases living in the HSE Eastern Region increased by more than
two years during the period under review. The median age of new cases was marginally lower than the median
age of previously treated cases between 1998 and 2002 (Table 15). The proportion of all treated cases under 18
years of age living in the HSE Eastern Region decreased by almost 5 per cent over the reporting period. As
expected, the proportion of cases under 18 years of age was much higher among new cases (13%) than among
those previously treated (2%). Overall, 67 per cent of treated cases living in the HSE Eastern Region were male.
From 1998 to 2002, there was a marginal decrease in the proportion of male cases treated for problem drug
use for the first time and living in the HSE Eastern Region. From 1998 to 2002, the proportion of cases who
lived with their parents or family decreased, from 66 per cent in 1998 to 56 per cent in 2002; this trend was
similar for both new and previously treated cases. Overall, 29 per cent of treated cases living in the HSE Eastern
Region in the period under review had left school early. The proportions were higher among previously treated
cases (30%) than among new cases (24%). It is clear that early school leavers are more common among those
seeking treatment for problem drug use, but the exact relationship between leaving school early and problem
drug use is unclear. From 1998 to 2002, less than one-quarter of all treated drug users living in the HSE Eastern
Region were employed. This may indicate that those with drug problems are less likely to find or retain
employment. This emphasises the importance of close linkages between treatment interventions and social,
educational and occupational reintegration programmes. 
Trends in treated problem drug use in the Health Service Executive Eastern Region, 1998 to 2002
Drug Misuse Research Division 19
Table 14   Risk behaviours among new cases, by HSE area of residence, and reported to the NDTRS, 1998
to 2002
Injecting and sharing status East Coast South Western Northern Dublin Wicklow
Area Area Area unspecified unspecified
New cases – 470 2106 1713 412 38 
injector status known
Median age (range)* 15 (11-21) 15 (11-22) 15 (12-23) 14 (11-22) 14 (11-28) 
started drug use, in years
Median age (range)* 19 (15-29) 19 (15-28) 19 (15-32) 18 (14-31) 18 (15-*) 
started injecting, in years
Number (%) ever injected 292 (62.1) 1043 (49.5) 904 (52.8) 230 (55.8) 17 (44.7) 
Of whom:†
‘ever shared’ 175 (59.9) 474 (45.4) 499 (55.2) 87 (37.8) 5 (29.4) 
‘currently injecting’ 196 (67.1) 551 (52.8) 603 (66.7) 139 (60.4) 6 (35.3) 
‘currently sharing’ 61 (20.9) 129 (12.4) 180 (19.9) 24 (10.4) 2 (11.8) 
* Age range presented is the 5th to 95th percentile (90% of all cases are within this age range).
† From the data presented in this table, it is not possible to ascertain the exact percentage of injectors with each risk factor of interest because not all declared
injectors were asked the subsequent injecting questions. 
The socio-economic characteristics of new cases living in each of the three HSE areas were examined for the
period 1998 to 2002 (Table 16). The HSE Northern Area had higher proportions of treated drug users living in
the area who were under 18 years of age, were still at school or were early school leavers than did the other
two HSE areas. The lowest proportion of cases continuing to reside with parents or family lived in the HSE
Northern Area. 
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Table 15   Socio-demographic characteristics of cases living in the HSE Eastern Region, by treatment
status, and reported to the NDTRS, 1998 to 2002 
Characteristics* 1998 1999 2000 2001 2002
All cases* 5083 5152 5323 5868 6248 
Median age (range)† in years 23.9 (17.4-37.7) 24.7 (18.4-38.4) 25.4 (18.7-38.9) 26.0 (19.1-39.9) 26.5 (19.2-40.6) 
Number (%) under 18 years of age 387 (7.6) 213 (4.2) 180 (3.4) 161 (2.8) 169 (2.7) 
Number (%) of males 3423 (68.4) 3445 (67.0) 3601 (67.8) 3949 (68.0) 3972 (67.0) 
Number (%) living with parents/family 3309 (65.8) 3102 (60.5) 3098 (58.9) 3276 (60.2) 3278 (56.0) 
Number (%) homeless § § § 381 (7.4) 371 (6.8)
Number (%) of early school leavers‡ 1210 (29.1) 1215 (28.4) 1433 (30.9) 1527 (29.5) 1585 (28.5) 
Number (%) still in school 93 (8.9) 70 (9.2) 56 (9.9) 33 (6.9) 62 (13.4) 
Number (%) aged 16 to 64 years employed 865 (18.2) 1267 (26.0) 1358 (26.8) 1347 (24.4) 1337 (22.8) 
Previously treated cases* 3815 3989 4293 4885 5324 
Median age (range)† in years 24.8 (18.3-38.7) 25.5 (19.0-38.8) 26.1 (19.5-39.1) 26.5 (19.8-40.2) 27.0 (20.0-40.7) 
Number (%) under 18 years of age 155 (4.1) 87 (2.2) 68 (1.6) 64 (1.3) 65 (1.2) 
Number (%) of males 2354 (67.5) 2632 (66.1) 2844 (66.4) 3281 (67.9) 3353 (66.6) 
Number (%) living with parents/family 2406 (63.8) 2318 (58.4) 2420 (57.0) 2690 (59.3) 2747 (54.9) 
Number (%) homeless § § § 309 (7.2) 313 (6.7)
Number (%) of early school leavers‡ 959 (29.6) 985 (29.4) 1262 (32.7) 1331 (30.6) 1411 (29.4) 
Number (%) still in school 18 (3.2) 16 (3.8) 6 (1.9) 8 (3.0) 12 (4.6) 
Number (%) aged 16 to 64 years employed 598 (16.5) 928 (24.5) 1086 (26.4) 1130 (24.5) 1183 (23.5) 
New cases* 1140 1080 958 903 790 
Median age (range)† in years 21.1 (16.1-32.0) 22.3 (16.8-36.0) 22.8 (16.4-36.6) 23.2 (17.0-36.5) 23.4 (16.1-38.4) 
Number (%) under 18 years of age 216 (19.0) 119 (11.0) 108 (11.3) 95 (10.7) 99 (12.6) 
Number (%) of males 810 (71.8) 749 (69.5) 699 (73.1) 610 (68.3) 526 (68.7) 
Number (%) living with parents/family 835 (74.0) 731 (67.9) 648 (68.2) 559 (65.5) 480 (63.9) 
Number (%) homeless § § § 63 (7.7) 50 (6.9)
Number (%) of early school leavers‡ 228 (26.7) 221 (25.3) 162 (22.0) 182 (23.5) 155 (23.3) 
Number (%) still in school 70 (16.2) 51 (16.1) 50 (20.8) 24 (12.2) 48 (25.1) 
Number (%) aged 16 to 64 years employed 243 (23.4) 321 (31.2) 255 (28.4) 204 (24.2) 136 (18.8)
Status unknown 128 83 72 80 134
* It is not possible to ascertain the percentage with each characteristic of interest from the total number because not all forms had complete data. 
† Age range presented is the 5th to 95th percentile (90% of all cases are within this age range).
‡ Left school before the age of 15 years.
§ Not applicable
Table 16   Socio-demographic characteristics of new cases, by HSE area of residence, and reported to the
NDTRS, 1998 to 2002 
Characteristics East Coast South Western Northern Dublin Wicklow
Area Area Area unspecified unspecified
New cases* 483 2157 1754 433 41
Median age (range)† in years 22.4 (17.1-38.6) 22.3 (16.9-34.8) 22.8 (15.8-35.9) 22.1 (16.3-36.7) 22.9 (17.1-52.1)
Number (%) under 18 years of age 45 (9.4) 251 (11.7) 270 (15.4) 68 (15.8) 3 (7.3) 
Number (%) of males 341 (71.3) 1515 (70.7) 1193 (68.9) 310 (72.3) 35 (85.4) 
Number (%) living with parents/family 334 (71.5) 1524 (71.9) 1175 (68.2) 190 (46.7) 30 (75.0) 
Number (%) of early school leavers‡ 87 (22.7) 394 (22.4) 385 (26.9) 76 (25.1) 6 (20.7) 
Number (%) still in school 20 (16.4) 79 (12.8) 133 (27.7) 9 (6.3) 2 (15.4) 
Number (%) aged 16 to 64 years employed 121 (26.6) 537 (26.4) 418 (25.9) 71 (18.2) 12 (30.8) 
* It is not possible to ascertain the percentage with each characteristic of interest from the total number because not all forms had complete data. 
† Age range presented is the 5th to 95th percentile (90% of all cases are within this age range).
‡ Left school before the age of 15 years.
Figures 5a, 5b and 5c present the age at which new cases living in the HSE Eastern Region commenced use of
their main problem drug for the period 1998 to 2002. The majority of cases commenced use of opiates,
cannabis, ecstasy and cocaine in their mid to late teens. The numbers reporting use of benzodiazepines,
amphetamines and volatile inhalants were small. 
Figure 5a   Age commenced use of main problem drug for new cases living in the HSE Eastern Region and
reported to the NDTRS, 1998 to 2002
Figure 5b   Age commenced use of main problem drug (excluding opiates) for new cases living in the
HSE Eastern Region and reported to the NDTRS, 1998 to 2002
Figure 5c   Age commenced use of main problem drug (excluding opiates and cannabis) for new cases
living in the HSE Eastern Region and reported to the NDTRS, 1998 to 2002
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Figures 6a, 6b and 6c present the age at which new cases living in the HSE Eastern Region sought treatment, by
the main problem drug, for the period 1998 to 2002. Although the numbers using volatile inhalants are small,
it is the main problem drug for a very young client group. It is evident that cannabis and ecstasy are the drugs
that young people seek treatment for in their late teens, while the majority of opiate and cocaine users seek
treatment in their early to mid twenties. 
Figure 6a   Age attended first treatment, by main problem drug, for new cases living in the HSE Eastern
Region and reported to the NDTRS, 1998 to 2002
Figure 6b   Age attended first treatment, by main problem drug (excluding opiates), for new cases living
in the HSE Eastern Region and reported to the NDTRS, 1998 to 2002
Figure 6c   Age attended first treatment, by main problem drug (excluding opiates and cannabis), for
new cases living in the HSE Eastern Region and reported to the NDTRS, 1998 to 2002
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Figure 7 presents the gender of new treated cases living in the HSE Eastern Region, by the main problem drug, for
the period 1998 to 2002. The proportions of males treated for amphetamine, ecstasy, cocaine and cannabis use
were very high compared to those of their female counterparts. The proportion of males treated for opiate use was
also higher than that of females, while there was a slightly higher proportion of males than females treated for use
of volatile inhalants. A higher proportion of females than males was treated for benznzodiazepine use.
Figure 7   Main problem drug, by gender, for new cases living in the HSE Eastern Region and reported to
the NDTRS, 1998 to 2002
Figure 8 presents the employment status, by the main problem drug, of new cases living in the HSE Eastern
Region who sought treatment in the period 1998 to 2002. The highest rates of employment were among those
who used drugs commonly associated with social events, and the lowest rates of employment were among
those who used opiates and benzodiazepines. This has important implications for the social and occupational
reintegration of opiate and benzodiazepine users.
Figure 8   Main problem drug, by regular employment, for new cases aged between 16 and 64 years
living in the HSE Eastern Region and reported to the NDTRS, 1998 to 2002
Figure 9 presents the route of administration of the main problem drug reported by new cases living in the HSE
Eastern Region who sought treatment between 1998 and 2002. Injecting drug use was associated with opiates
and, to a lesser extent, with cocaine and amphetamines. 
Figure 9   Route of administration of selected main problem drugs for new cases living in the HSE Eastern
Region and reported to the NDTRS, 1998 to 2002
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Conclusions
Overall, the total number of cases treated for problem drug use living in the HSE Eastern Region and reported
to the NDTRS increased by 23 per cent between 1998 and 2002. The number of previously treated cases
returning to or continuing in treatment increased by 40 per cent, from 3,815 in 1998 to 5,324 in 2002. There
was a 31 per cent decrease in the number of new cases, from 1,140 in 1998 to 790 in 2002. The decrease in
new cases may be due to a combination of factors: a decrease in drug use, a change in the pattern of drug use
that was not accommodated in the treatment services, or an inadequate number of treatment places to
accommodate the needs of new problem drug users (because chronic drug users occupy the available
treatment places). The most likely explanation is a decrease in the number of new opiate users in the region.
According to the clinical director in the HSE South Western Area, the length of the waiting list or of waiting
times did not increase significantly between 1998 and 2002 (Dr Eamon Keenan, personal communication,
2005) therefore, the third explanation is unlikely. Both new and previously treated cases living in the HSE
Eastern Region between 1998 and 2002 most frequently reported that opiates were their main problem drug.
The total number of treated cases reporting cocaine as their main problem drug increased by almost 30 per
cent. The wide spectrum of problem drug types reported indicates that treatment services need to cater for a
number of licit and illicit drugs used rather than focusing on one or two drugs. Polydrug use remains a
common practice that needs to be addressed in a client’s treatment plan. Benzodiazepines, cannabis and
cocaine are important additional problem drugs and, as such, need to be addressed in treatment programmes.
The incidence of treated drug use among persons aged between 15 and 64 years increased in three of the 13
drugs task force areas between the two overlapping time periods, 1998 to 2000 and 2000 to 2002. The
incidence in Bray more than doubled (from 41 per 100,000 to 100 per 100,000). In Dunlaoghaire–Rathdown
the incidence increased by 55 per cent (from 31 per 100,000 to 48 per 100,000), while in Finglas–Cabra the
incidence also increased (from 101 per 100,000 to 133 per 100,000). The incidence of treated drug use in nine
of the 13 drugs task force areas decreased. Ballyfermot experienced a 44 per cent decrease in incidence (from
370 per 100,000 to 206 per 100,000), followed by the Canal Communities, which experienced a 40 per cent
decrease (from 383 per 100,000 to 228 per 100,000). In Blanchardstown the incidence of treated drug use
decreased by 39 per cent (from 117 per 100,000 to 71 per 100,000), while in Ballymun it decreased by 38 per
cent (from 551 per 100,000 to 339 per 100,000). The incidence in the South Inner City remained largely
unchanged over the two time periods. This demonstrates the importance of analysis by small areas in order to
identify the shift of problematic drug use to new areas. 
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